Asia Pacific Clinical Trials Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Clinical Trials Market – By Phase

1.3.2 Asia Pacific Clinical Trials Market – By Study Design

1.3.3 Asia Pacific Clinical Trials Market – By Indication

1.3.4 Asia Pacific Clinical Trials Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Clinical Trials Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Asia Pacific PEST Analysis

4.3 Experts Opinion

5. Asia Pacific Clinical Trials Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Adoption and Outsourcing of Clinical Trials

5.1.2 Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry

5.2 Market Restraints

5.2.1 Expensive and Time-Consuming Process

5.3 Market Opportunities

5.3.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials

5.4 Future Trends

5.4.1 AI-Driven Clinical Trials

5.5 Impact Analysis

6. Clinical Trials Market – Asia Pacific Analysis

6.1 Asia Pacific Clinical Trials Market Revenue Forecast and Analysis

7. Asia Pacific Clinical Trials Market Revenue and Forecast To 2028 – by Study Design

7.1 Overview

7.2 Asia Pacific Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)

7.3 Interventional

7.3.1 Overview

7.3.2 Interventional: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Observational

7.4.1 Overview

7.4.2 Observational: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Expanded Access

7.5.1 Overview

7.5.2 Expanded Access: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Clinical Trials Market – By Phase

8.1 Overview

8.2 Asia Pacific Clinical Trials Market, by Phase, 2022 and 2028 (%)

8.3 Phase III

8.3.1 Overview

8.3.2 Phase III: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Phase II

8.4.1 Overview

8.4.2 Phase II: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Phase IV

8.5.1 Overview

8.5.2 Phase IV: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Phase I

8.6.1 Overview

8.6.2 Phase I: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Clinical Trials Market Revenue and Forecast To 2028 – Indication

9.1 Overview

9.2 Asia Pacific Clinical Trials Market Revenue Share, by Indication (2022 and 2028)

9.3 Autoimmune/Inflammation

9.3.1 Overview

9.3.2 Autoimmune/Inflammation: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Pain Management

9.4.1 Overview

9.4.2 Pain Management: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Oncology

9.5.1 Overview

9.5.2 Oncology: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.6 CNS Condition

9.6.1 Overview

9.6.2 CNS Condition: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.7 Diabetes

9.7.1 Overview

9.7.2 Diabetes: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.8 Obesity

9.8.1 Overview

9.8.2 Obesity: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.9 Cardiovascular

9.9.1 Overview

9.9.2 Cardiovascular: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.10 Other

9.10.1 Overview

9.10.2 Other: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 – Country Analysis

10.1.1 Asia Pacific: Clinical Trials Market

10.1.1 Overview

10.1.1.1 China: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 China: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 China: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)

10.1.1.1.4 China: Clinical Trials Market, by Study Design, 2020–2028 (US$ Million)

10.1.1.1.5 China: Clinical Trials Market, by Indication, 2020–2028 (US$ Million)

10.1.1.2 Japan: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Japan: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 Japan: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)

10.1.1.2.4 Japan: Clinical Trials Market, by Study Design, 2020–2028 (US$ Million)

10.1.1.2.5 Japan: Clinical Trials Market, by Indication, 2020–2028 (US$ Million)

10.1.1.3 India: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 India: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 India: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)

10.1.1.3.4 India: Clinical Trials Market, by Study Design, 2020–2028 (US$ Million)

10.1.1.3.5 India: Clinical Trials Market, by Indication, 2020–2028 (US$ Million)

10.1.1.4 Australia: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Australia: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3 Australia: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)

10.1.1.4.4 Australia: Clinical Trials Market, by Study Design, 2020–2028 (US$ Million)

10.1.1.4.5 Australia: Clinical Trials Market, by Indication, 2020–2028 (US$ Million)

10.1.1.5 South Korea: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 South Korea: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3 South Korea: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)

10.1.1.5.4 South Korea: Clinical Trials Market, by Study Design, 2020–2028 (US$ Million)

10.1.1.5.5 South Korea: Clinical Trials Market, by Indication, 2020–2028 (US$ Million)

10.1.1.6 Rest of Asia Pacific: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Asia Pacific: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3 Rest of Asia Pacific: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)

10.1.1.6.4 Rest of Asia Pacific: Clinical Trials Market, by Study Design, 2020–2028 (US$ Million)

10.1.1.6.5 Rest of Asia Pacific: Clinical Trials Market, by Indication, 2020–2028 (US$ Million)

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies Done by the Companies in the Market, (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 IQVIA Holdings Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Parexel International Corp

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Charles River Laboratories International Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 ICON Plc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 WuXi AppTec Co Ltd

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 SGS SA

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Syneos Health Inc

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 SIRO Clinpharm Pvt Ltd

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Thermo Fisher Scientific Inc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Laboratory Corp of America Holdings

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. China Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 2. China Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 3. China Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 4. Japan Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 5. Japan Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 6. Japan Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 7. India Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 8. India Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 9. India Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 10. Australia Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 11. Australia Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 12. Australia Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 13. South Korea Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 14. South Korea Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 15. South Korea Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 16. Rest of Asia Pacific Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 17. Rest of Asia Pacific Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 18. Rest of Asia Pacific Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 19. Organic Developments Done by Companies

Table 20. Inorganic Developments Done by Companies

Table 21. Glossary of Terms

LIST OF FIGURES

Figure 1. Asia Pacific Clinical Trials Market Segmentation

Figure 2. Asia Pacific Clinical Trials Market, By Region

Figure 3. Asia Pacific Clinical Trials Market Overview

Figure 4. Phase III Segment Held Largest Share of Phase Segment in Asia Pacific Clinical Trials Market

Figure 5. India is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Asia Pacific: PEST Analysis

Figure 7. Experts Opinion

Figure 8. Impact Analysis

Figure 9. Asia Pacific Clinical Trials Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10. Asia Pacific Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)

Figure 11. Interventional: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Observational: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Expanded Access: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Asia Pacific Clinical Trials Market, by Phase 2022 and 2028 (%)

Figure 15. Phase III: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Phase II: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Phase IV: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Phase I: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Asia Pacific Clinical Trials Market Revenue Share, by Indication (2022 and 2028)

Figure 20. Autoimmune/Inflammation: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Pain Management: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Oncology: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. CNS Condition: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Diabetes: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Obesity: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Cardiovascular: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Other: Asia Pacific Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Asia Pacific: Clinical Trials Market, by Key Country – Revenue (2022) (US$ Million)

Figure 29. Asia Pacific: Clinical Trials Market, by Country, 2022 & 2028 (%)

Figure 30. China: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Japan: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. India: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Australia: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. South Korea: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Rest of Asia Pacific: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. Growth Strategies Done by the Companies in the Market, (%)